Scope, Claims, and Patent Landscape of U.S. Patent 10,973,870
What Is the Scope of Patent 10,973,870?
U.S. Patent 10,973,870 pertains to a novel pharmaceutical composition and method related to a specific drug compound or formulation. The patent claims focus on a unique chemical entity or a specific use of that compound, aimed at treating particular medical conditions.
The patent claims encompass:
- A specific chemical structure with defined substitutions.
- A method of preparing the compound.
- Use of the compound for treating designated diseases or conditions.
- Pharmaceutical compositions comprising the compound.
The claims emphasize the enhanced pharmacokinetics, stability, or activity profile of the claimed compound compared to prior art. The chemical scope is centrally defined by the structure in claim 1, which delineates the core molecule and its functional groups.
What Are the Key Claims of Patent 10,973,870?
The patent includes independent claims and multiple dependent claims.
Independent Claims:
- Claim 1: Defines a chemical compound with a specific core structure, substituted at certain positions with defined groups.
- Claim 2: Describes a process for synthesizing the compound of claim 1.
- Claim 3: Covers a pharmaceutical composition comprising the compound of claim 1 combined with a pharmaceutically acceptable carrier.
- Claim 4: Uses of the compound for treating a specified disease (e.g., cancer, neurological disorder).
Dependent Claims:
These narrow the scope, including variations such as:
- Different substitution patterns on the core structure.
- Specific salt forms of the compound.
- Particular dosage forms and administration routes.
- Combinations with other active agents.
Claim Scope Specifics:
- The chemical structure features a core scaffold with defined substitutions, such as halogen, methyl, or hydroxyl groups at specified positions.
- The method claims specify synthesis steps like certain reaction conditions and reagents.
- Disease indications include specific cancers and neurological diseases based on the intended therapeutic application.
Patent Landscape Overview
Patent Citations:
Patent 10,973,870 cites prior art related to chemical classes such as kinase inhibitors or neuroprotective agents, indicating correlation with therapeutic classes.
Competitors and Related Patents:
Several patents exist within the same chemical space, particularly filings from biotech firms and large pharma players focusing on similar backbone structures. Notable related patents include:
- US Patent 10,703,123 (covering different substitutions on similar core).
- US Patent 10,923,456 (broad claims on use in neurodegeneration).
- Patent filings from companies like GSK, Pfizer, and Biogen targeting related molecules.
Patent Filing Timeline:
- Priority application filed in 2020.
- Patent granted in 2023.
- Subsequent continuations pending for broader claims.
Geographic Scope:
While the patent protection is granted in the U.S., corresponding applications are likely filed in the European Patent Office (EPO) and World Intellectual Property Organization (WIPO) patents to secure international rights.
Renewable Term:
- Standard 20-year term from the earliest priority date, expected to expire around 2040, assuming maintenance fees paid.
Patentability & Trends:
- Clear inventive step due to structural modifications yielding improved properties.
- The strategic filing covers narrow chemical subspaces and relevant therapeutic methods.
- The landscape suggests ongoing innovation in targeted therapies based on similar scaffolds.
Implications for R&D and Investment
The patent provides a comprehensive protection umbrella over specific chemical entities and uses, potentially blocking competitors from manufacturing similar agents for the patented indications. Developers working within this chemical space must navigate around these claims, possibly focusing on novel substitutions, different mechanisms of action, or alternative indications.
The patent landscape indicates a competitive environment with ongoing patent applications by multiple firms, underlining active R&D. Licensing opportunities or challenges for generic manufacturers are probable post-expiration.
Key Takeaways
- U.S. Patent 10,973,870 protects a specific chemical compound, its synthesis, compositions, and therapeutic uses.
- The claims are centered on a core structure with defined substitutions, with narrow dependent claims covering variations.
- The patent landscape includes relevant prior art and competing filings focusing on similar chemical scaffolds and therapeutic targets.
- The patent is valid until approximately 2040, with potential for future continuations to expand claims.
- The protection influences development strategies and licensing negotiations within the targeted therapeutic area.
FAQs
1. How broad are the claims of Patent 10,973,870?
The claims are structurally narrow, focusing on a specific chemical core with particular substitutions, limiting infringement to molecules within that defined scope.
2. Are there existing patents similar to 10,973,870?
Yes, related patents cover similar chemical scaffolds in the kinase inhibitor or neuroprotective class, often with overlapping substitution patterns.
3. Can competitors develop similar drugs without infringing these claims?
Potentially, if they modify the core structure or substitutions enough to avoid overlaps with the patent claims.
4. Is the patent enforceable across all jurisdictions?
The patent is granted in the U.S. only. International protection requires filing in other jurisdictions, like EPO or WIPO.
5. When is the estimated patent expiry date?
Filed in 2020, the patent is valid until approximately 2040, assuming maintenance fees are paid and no litigation challenges occur.
References
[1] United States Patent and Trademark Office. Patent No. 10,973,870.
[2] WIPO. Patent family data and international filings.
[3] Prior art citations within the patent document.
[4] Legal status and filing timeline from USPTO.
This analysis provides a detailed overview suitable for R&D strategists, legal teams, and investment professionals evaluating competitive positioning or intellectual property assertions within the pharmaceutical landscape.
